Skip to content
ClinCalc Pro
Menu
Mood stabiliser (liquid)

Lithium citrate

Brand names: Li-Liquid, Priadel liquid

Lithium citrate is a lithium salt used as a mood stabiliser in the treatment and prophylaxis of bipolar disorder and recurrent depression, and to control mania.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Its precise mechanism is uncertain, but lithium is thought to modulate neuronal signal transduction, including effects on second-messenger systems, to stabilise mood.

Prescribing in practice

  • Lithium has a narrow therapeutic index, and toxicity can be life-threatening, so serum lithium concentrations must be monitored and patients warned about precipitants such as dehydration, infection and interacting drugs.
  • Different lithium preparations vary in bioavailability, so the brand should not be changed without re-checking serum levels.
  • Renal, thyroid and cardiac function require assessment before and during treatment, as lithium can affect the kidneys and thyroid.

Monitoring

Monitor serum lithium concentrations regularly, together with renal and thyroid function, and review for signs of toxicity such as tremor, vomiting, diarrhoea and confusion.

Counselling the patient

  • Maintain a consistent fluid and salt intake and avoid becoming dehydrated.
  • Carry a lithium alert card and attend for blood tests as scheduled.
  • Seek urgent advice for coarse tremor, persistent vomiting, diarrhoea or drowsiness.

Evidence & guidelines

Lithium is a long-established, evidence-based mood stabiliser recommended by NICE for bipolar disorder, with the MHRA emphasising the need for routine monitoring.

Reference: NICE CG185; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.